Evidence reviewed through:
⚕️ This article is education, not medical advice. Every claim is sourced below. Never stop or change medication without your prescriber — some medications are dangerous to stop abruptly.
CBT-I for COMISA: Treating Insomnia Alongside Sleep Apnea and PAP
Key answer
Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment for chronic insomnia. It combines assessment, stimulus control, sleep scheduling or sleep-restriction methods, cognitive strategies, and relapse prevention. The treatment can be delivered in person, by telehealth, in groups, or through validated digital programs, but the components and level of supervision may need adaptation when another condition changes the safety of sleep loss or the interpretation of symptoms. [1–3]
At a glance
| Question | Evidence-based answer |
|---|---|
| Is CBT-I the same as sleep hygiene? | No. Sleep hygiene is supportive education; multicomponent CBT-I is an active treatment. [1] |
| Does it work with comorbid illness? | Often yes, and guidelines recommend it across many comorbidities, but parallel illnesses still need parallel care. [2,3] |
| Can it be digital? | Validated digital CBT-I can be effective; therapist support, engagement, and complexity influence results. |
| Is sleep restriction always used unchanged? | No. Time-in-bed reduction may need adaptation for bipolar disorder, seizure risk, excessive sleepiness, falls, pregnancy, or unstable illness. [3] |
| Does CBT-I guarantee medication discontinuation or cure another condition? | No. It treats insomnia mechanisms and may support other goals, but it does not erase medication-specific risk or replace other treatment. |
What CBT-I includes
A full program usually begins with a sleep and medical history plus a sleep diary. Stimulus control strengthens the connection between bed and sleep. Sleep scheduling or sleep restriction therapy reduces excessive time awake in bed and later expands the sleep window as sleep consolidates. Cognitive strategies test catastrophic predictions and unhelpful monitoring. Relapse-prevention planning prepares for travel, illness, stress, medication changes, or symptom flares. Relaxation and sleep-hygiene education may support the program but do not replace the core treatment. [1–3]
Why both conditions must be treated
COMISA means comorbid insomnia and obstructive sleep apnea. CBT-I does not splint the airway open, and positive airway pressure (PAP) does not necessarily remove conditioned insomnia. Untreated sleep apnea can make sleep restriction riskier because daytime sleepiness and driving risk may already be elevated.
In the MATRICS randomized trial, adding CBT-I to PAP improved insomnia outcomes compared with PAP alone but did not significantly improve PAP adherence; sequential and concurrent CBT-I produced similar outcomes. A separate randomized trial found that CBT-I before CPAP improved both insomnia and average CPAP use. These differing results show why one trial should not be turned into a universal sequencing rule. [4,5]
A practical parallel-care model
| Problem | Main treatment target |
|---|---|
| Airway obstruction and oxygen-related events | PAP, oral appliance, surgery, weight-related care, positional or other OSA treatment as clinically appropriate. |
| Conditioned wakefulness and insomnia behaviors | CBT-I. |
| Mask anxiety, leak, pressure discomfort | PAP troubleshooting, desensitization, equipment review. |
| Excessive sleepiness or safety risk | Prompt review before aggressive time-in-bed restriction. |
Timing and monitoring
CBT-I may start before PAP, at the same time, or after PAP begins. The choice depends on sleepiness, access, adherence barriers, and clinical urgency. Track PAP use and residual events separately from the insomnia diary. A better insomnia score does not prove that OSA is controlled.
Safety and adaptation
Transient sleepiness can occur when time in bed is compressed. A trained clinician should review driving, safety-sensitive work, falls, untreated sleep apnea, uncontrolled seizure disorder, bipolar disorder, active substance-use problems, acute suicidality or psychosis, pregnancy or postpartum demands, and unstable medical illness. The response may be a gentler sleep-compression approach, a wider initial sleep window, closer monitoring, treatment of another disorder first, or referral to a behavioral sleep medicine specialist. [3]
What to track
Track bedtime, final wake time, estimated sleep onset, awakenings, naps, daytime sleepiness, functional safety, relevant symptoms, medication timing, alcohol or other sedatives, and adherence to the agreed components. Wearables can show trends but do not diagnose insomnia or sleep apnea and should not overrule a clinical assessment.
Questions to take to the clinical team
- Has insomnia disorder been assessed, or could another sleep disorder explain the pattern?
- Which CBT-I components are appropriate now, and which need adaptation?
- What outcome will be monitored: insomnia severity, function, medication use, mood, pain, PAP use, or another goal?
- What symptoms require stopping the self-guided plan and contacting the team?
- Is the digital or group program validated, and is clinician support available if progress stalls?
Frequently asked questions
Can CBT-I cure sleep apnea?
No. It treats insomnia, not upper-airway obstruction.
Must PAP begin before CBT-I?
Not always. Trials have tested both sequential and concurrent models, and the best sequence is individualized.
Can sleep restriction worsen sleepiness?
Yes temporarily, which is why untreated or severe OSA and driving risk require adaptation and monitoring.
Does CBT-I always improve PAP adherence?
No. Some trials found improvement and others did not; insomnia outcomes are more consistent than adherence outcomes.
References
-
Edinger JD, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. 2021. Evidence type: Clinical practice guideline. Use: Strong recommendation for multicomponent CBT-I; sleep hygiene alone is not an adequate stand-alone treatment.
-
Riemann D, et al. The European Insomnia Guideline: an update on diagnosis and treatment of insomnia 2023. Evidence type: European guideline. Use: CBT-I as first-line treatment in adults of any age, including comorbidities, in-person or digitally.
-
VA/DoD. Clinical Practice Guideline for the Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea. 2025. Evidence type: National clinical practice guideline. Use: Delivery options, diagnostic screening, and situations requiring adaptation or delay.
-
Ong JC, et al. CBT-I and PAP for OSA with comorbid insomnia: MATRICS randomized trial. 2020. Evidence type: Randomized trial. Use: Better insomnia outcomes without significant PAP-adherence improvement; no clear sequence advantage.
-
Sweetman A, et al. CBT-I before CPAP in COMISA: randomized trial. 2019. Evidence type: Randomized trial. Use: Improved insomnia and average CPAP adherence in the studied population.
-
Tu AY, et al. CBT-I and PAP effects on sleep and daytime performance. 2022. Evidence type: Randomized-trial secondary outcomes. Use: Sleep and daytime outcomes; not a replacement for OSA treatment.
Bring real data to your doctor
Generate a clinician-ready Doctor Report in SBAR format with trend charts, plus clean CSV and PDF exports. Walk into your next appointment with evidence, not guesswork.
RxDown is a data tracking and journaling tool for adults (18+). It does not provide medical advice, diagnosis, or treatment. Never stop taking medication or change your dose based solely on information from this app or website — medication reduction should always be supervised by a qualified healthcare professional.